(19)
(11) EP 3 328 988 A1

(12)

(43) Date of publication:
06.06.2018 Bulletin 2018/23

(21) Application number: 16751733.3

(22) Date of filing: 29.07.2016
(51) International Patent Classification (IPC): 
C12N 1/00(2006.01)
A61K 35/74(2015.01)
(86) International application number:
PCT/US2016/044922
(87) International publication number:
WO 2017/023818 (09.02.2017 Gazette 2017/06)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 31.07.2015 US 201562199445 P
13.05.2016 WO PCT/US2016/032565
13.05.2016 US 201662336338 P
25.05.2016 US 201662341320 P
10.06.2016 WO PCT/US2016/037098

(71) Applicant: Synlogic, Inc.
Cambridge, MA 02139 (US)

(72) Inventors:
  • FALB, Dean
    Sherborn, MA 01770 (US)
  • MILLER, Paul
    Salem, CT 06420 (US)
  • TUCKER, Alex
    Somerville, MA 02143 (US)
  • KOTULA, Jonathan
    Somerville, MA 02143 (US)
  • ISABELLA, Vincent
    Cambridge, MA 02139 (US)
  • MILLET, Yves
    Newton, MA 02460 (US)

(74) Representative: Murgitroyd & Company 
Scotland House 165-169 Scotland Street
Glasgow G5 8PL
Glasgow G5 8PL (GB)

   


(54) BACTERIA ENGINEERED TO TREAT DISORDERS INVOLVING PROPIONATE CATABOLISM